Publication:
CRISPR-Cas3 induces broad and unidirectional genome editing in human cells

dc.contributor.authorHiroyuki Morisakaen_US
dc.contributor.authorKazuto Yoshimien_US
dc.contributor.authorYuya Okuzakien_US
dc.contributor.authorPeter Geeen_US
dc.contributor.authorYayoi Kunihiroen_US
dc.contributor.authorEkasit Sonphoen_US
dc.contributor.authorHuaigeng Xuen_US
dc.contributor.authorNoriko Sasakawaen_US
dc.contributor.authorYuki Naitoen_US
dc.contributor.authorShinichiro Nakadaen_US
dc.contributor.authorTakashi Yamamotoen_US
dc.contributor.authorShigetoshi Sanoen_US
dc.contributor.authorAkitsu Hottaen_US
dc.contributor.authorJunji Takedaen_US
dc.contributor.authorTomoji Mashimoen_US
dc.contributor.otherCenter for iPS Cell Research and Applicationen_US
dc.contributor.otherInstitute of Medical Science The University of Tokyoen_US
dc.contributor.otherHiroshima Universityen_US
dc.contributor.otherOsaka Universityen_US
dc.contributor.otherNational Institute of Genetics Mishimaen_US
dc.contributor.otherKochi Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherDatabase Center for Life Science (DBCLS)en_US
dc.date.accessioned2020-01-27T07:35:22Z
dc.date.available2020-01-27T07:35:22Z
dc.date.issued2019-12-01en_US
dc.description.abstract© 2019, The Author(s). Although single-component Class 2 CRISPR systems, such as type II Cas9 or type V Cas12a (Cpf1), are widely used for genome editing in eukaryotic cells, the application of multi-component Class 1 CRISPR has been less developed. Here we demonstrate that type I-E CRISPR mediates distinct DNA cleavage activity in human cells. Notably, Cas3, which possesses helicase and nuclease activity, predominantly triggered several thousand base pair deletions upstream of the 5′-ARG protospacer adjacent motif (PAM), without prominent off-target activity. This Cas3-mediated directional and broad DNA degradation can be used to introduce functional gene knockouts and knock-ins. As an example of potential therapeutic applications, we show Cas3-mediated exon-skipping of the Duchenne muscular dystrophy (DMD) gene in patient-induced pluripotent stem cells (iPSCs). These findings broaden our understanding of the Class 1 CRISPR system, which may serve as a unique genome editing tool in eukaryotic cells distinct from the Class 2 CRISPR system.en_US
dc.identifier.citationNature Communications. Vol.10, No.1 (2019)en_US
dc.identifier.doi10.1038/s41467-019-13226-xen_US
dc.identifier.issn20411723en_US
dc.identifier.other2-s2.0-85076283383en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/50021
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85076283383&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectChemistryen_US
dc.titleCRISPR-Cas3 induces broad and unidirectional genome editing in human cellsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85076283383&origin=inwarden_US

Files

Collections